bioAffinity Technologies, Inc. (BIAF) stock
BIAFNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAFW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3071% below fair value
$1.93−0.07 (-3.50%)
Close on Nov 17, 2026Market cap $15.64MP/E –Yield –
bioAffinity Technologies enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
bioAffinity Technologies's enterprise value was -$1.30M on Nov 11, 2026, against -$2.17M a year earlier. Over the last 4 years it ranged from -$3.41M to $25.50M, with a median of $5.72M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.30M | – |
| 2025 | Dec 31, 2025 | -$3.28M | -128.2% |
| 2024 | Dec 31, 2024 | $11.61M | +28.4% |
| 2023 | Dec 29, 2023 | $9.04M | – |
| 2022 | Dec 30, 2022 | -$105.99K | – |
See a number that looks wrong?